|

Vinblastine Clinical Trials

8 actively recruiting trials across 3 locations

▲ +1 trial since August 2026

Also known as: ABVD, Velban

Pipeline

Phase 2: 4Phase 3: 3Phase 4: 1

Top Sponsors

  • University Hospital, Strasbourg, France1
  • University College, London1
  • Takeda1
  • State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia1
  • National Medical Research Radiological Centre of the Ministry of Health of Russia1

Indications

  • Cancer8
  • Hodgkin Lymphoma4
  • Hodgkin Lymphoma, Adult2
  • Gemcitabine1
  • Vinblastine1

Other5 trials

A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India
Phase 4
First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)
Phase 3
Nivo40-AVD for Advanced Classic Hodgkin Lymphoma
Phase 2
Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy
Phase 2
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
Phase 3

Stanford, California1 trial

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Stanford University - (Stanford Cancer Institute)

Phase 3

Miami, Florida1 trial

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

University of Miami

Phase 2

Houston, Texas1 trial

Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

UT MD Anderson

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.